The Combinostics cNeuro™ platform combines the company’s innovative AI technology with a holistic view of patient data (imaging biomarkers, demographic and clinical data, neuropsychology test results, and other biomarkers) to enable clinicians to make reliable, evidence-based diagnostic and management decisions for their patients with neurological disorders.